Bio-Connect
IHC-P analysis of rat liver tissue using GTX85014 JMJD1C antibody. Working concentration : 2.5 microg/ml
IHC-P analysis of rat liver tissue using GTX85014 JMJD1C antibody. Working concentration : 2.5 microg/ml
IHC-P analysis of rat liver tissue using GTX85014 JMJD1C antibody. Working concentration : 2.5 microg/ml

JMJD1C antibody

GTX85014
GeneTex
ApplicationsWestern Blot, ELISA, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Product group Antibodies
ReactivityHuman, Mouse, Rat
TargetJMJD1C
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    GeneTex
  • Product Name
    JMJD1C antibody
  • Delivery Days Customer
    9
  • Antibody Specificity
    This antibody will not cross-react with JMJD1A or JMJD1B.
  • Application Supplier Note
    WB: 1 - 2 microg/mL. IHC-P: 2.5 microg/mL. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
  • Applications
    Western Blot, ELISA, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
  • Certification
    Research Use Only
  • Clonality
    Polyclonal
  • Concentration
    1 mg/ml
  • Conjugate
    Unconjugated
  • Gene ID221037
  • Target name
    JMJD1C
  • Target description
    jumonji domain containing 1C
  • Target synonyms
    KDM3C; probable JmjC domain-containing histone demethylation protein 2C; thyroid hormone receptor interactor 8; thyroid receptor-interacting protein 8; TR-interacting protein 8; TRIP8; TRIP-8
  • Host
    Rabbit
  • Isotype
    IgG
  • Protein IDQ15652
  • Protein Name
    Probable JmjC domain-containing histone demethylation protein 2C
  • Scientific Description
    The jumonji domain containing 1C protein (JMJD1C) was initially discovered in silico, and later suggested to be a candidate gene for autism. Like the related proteins JMJD1A and JMJD1B, JMJD1C is a histone H3K9 demethylase implicated in the nuclear hormone receptor-based transcriptional regulation. JMJD1C mRNA is highly expressed in undifferentiated embryonic stem (ES) cells as well as pancreatic islet, diffuse-type gastric cancer, and other tissues and tumors. The JMJD1C gene promoter contain bHLH-, AP-1-, and POU5F1-binding sites, and as preferential expression of POU5F1 has been reported in ES cells, pancreatic islet, and diffuse-type gastric cancer, it has been suggested that POU5F1-mediated expression of JMJD1C reactivates previously silenced genes in ES cells and diffuse-type gastric cancer. At least three isoforms of JMJD1C are known to exist. This antibody will not cross-react with JMJD1A or JMJD1B.
  • Reactivity
    Human, Mouse, Rat
  • Storage Instruction
    -20°C or -80°C,2°C to 8°C
  • UNSPSC
    12352203